Fabio Efficace

Author PubWeight™ 37.68‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The prognostic significance of patient-reported outcomes in cancer clinical trials. J Clin Oncol 2008 3.14
2 An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. Eur J Cancer 2008 1.95
3 Patient-reported outcomes in randomized clinical trials: development of ISOQOL reporting standards. Qual Life Res 2012 1.62
4 Transfusions at home in patients with myelodysplastic syndromes. Leuk Res 2012 1.59
5 Health-related quality of life in survivors of locally advanced breast cancer: an international randomised controlled phase III trial. Lancet Oncol 2005 1.48
6 Do quality-of-life randomized clinical trials support clinicians in their decision-making? J Clin Oncol 2002 1.45
7 Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg 2011 1.16
8 The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative. Health Qual Life Outcomes 2013 1.08
9 Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma. J Clin Oncol 2007 1.08
10 Development of an EORTC quality of life phase III module measuring cancer-related fatigue (EORTC QLQ-FA13). Psychooncology 2012 1.01
11 EORTC QLQ-INFO26: a questionnaire to assess information given to cancer patients a preliminary analysis in eight countries. Psychooncology 2007 0.98
12 Imatinib treatment in chronic myelogenous leukemia: What have we learned so far? Cancer Lett 2010 0.98
13 Long-term health-related quality of life evaluated more than 20 years after hematopoietic stem cell transplantation for thalassemia. Blood 2013 0.98
14 Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study. J Clin Oncol 2007 0.97
15 Health-related quality of life in non-small-cell lung cancer: methodologic issues in randomized controlled trials. J Clin Oncol 2003 0.97
16 Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disord 2012 0.95
17 Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here? Haematologica 2007 0.93
18 Moving towards patient-centered decision-making in chronic myeloid leukemia: assessment of quality of life and symptom burden. Haematologica 2014 0.90
19 Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2010 0.90
20 Different perception of surgical risks between physicians and patients undergoing laparoscopic cholecystectomy. Surg Laparosc Endosc Percutan Tech 2009 0.89
21 Health-related quality of life outcomes in disease-free survivors of mid-low rectal cancer after curative surgery. Ann Surg Oncol 2008 0.87
22 Toward a clearer understanding of the prognostic value of health-related quality-of-life parameters in breast cancer. J Clin Oncol 2005 0.87
23 Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer: European Organization for Research and Treatment of Cancer Breast Cancer Group, Investigational Drug Branch for Breast Cancer and the New Drug Development Group Study. J Clin Oncol 2004 0.87
24 Standards are needed for quality of life clinical trials. BMJ 2002 0.83
25 Controlled-release oxycodone for the treatment of bortezomib-induced neuropathic pain in patients with multiple myeloma. Support Care Cancer 2012 0.83
26 Health-related quality of life, faecal continence and bowel function in rectal cancer patients after chemoradiotherapy followed by radical surgery. Support Care Cancer 2009 0.83
27 Cross-cultural development of an EORTC questionnaire to assess health-related quality of life in patients with testicular cancer: the EORTC QLQ-TC26. Qual Life Res 2012 0.80
28 Health-related quality of life and symptom assessment in patients with myelodysplastic syndromes. Expert Rev Hematol 2009 0.80
29 Patient-reported outcomes for the myelodysplastic syndromes: a new MDS-specific measure of quality of life. Blood 2014 0.80
30 Adherence to treatment is a complex and multifaceted issue that can substantially alter the outcome of chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Leuk Res 2012 0.79
31 Cross-cultural development of the EORTC QLQ-SWB36: a stand-alone measure of spiritual wellbeing for palliative care patients with cancer. Palliat Med 2012 0.79
32 Implementing patient-reported health-related quality-of-life data in cancer routine practice to improve accuracy of prognosis. Are we there yet? Expert Rev Pharmacoecon Outcomes Res 2009 0.78
33 Using patient-reported health status to improve prognostic assessment in patients with acute myeloid leukemia: current challenges and future applications. Haematologica 2013 0.78
34 Motor disability in the setting of oral anticoagulant therapy. Int J Hematol 2011 0.78
35 Asking patients with hematological malignancies: 'how do you feel?' Does it really provide independent prognostic information for survival? Eur J Haematol 2009 0.77
36 Reassessing the approach to informed consent: the case of unrelated hematopoietic stem cell transplantation in adult thalassemia patients. Philos Ethics Humanit Med 2014 0.77
37 Progressive arterial occlusive disease (PAOD) and pulmonary arterial hypertension (PAH) as new adverse events of second generation TKIs in CML treatment: who's afraid of the big bad wolf? Leuk Res 2012 0.77
38 The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes. Cardiovasc Hematol Agents Med Chem 2012 0.76
39 Variability and sample size requirements for health-related quality-of-life measures: understanding the challenges facing investigators. J Clin Oncol 2005 0.75
40 Pregnancy in acute promyelocytic leukaemia after front-line therapy with arsenic trioxide and all-trans retinoic acid. Br J Haematol 2014 0.75
41 Pain management in hematological patients with major organ dysfunctions and comorbid illnesses. Cardiovasc Hematol Agents Med Chem 2012 0.75
42 External beam radiotherapy in prostate cancer patients: short- and long-term health-related quality of life issues. Expert Rev Pharmacoecon Outcomes Res 2003 0.75
43 Cultural issues in assessing quality of life in cancer clinical trials. Expert Rev Pharmacoecon Outcomes Res 2002 0.75
44 The added value of propensity score matching when using health-related quality of life reference data. Stat Med 2013 0.75